The global market for cfDNA Testing was valued at US$ 1500 million in the year 2024 and is projected to reach a revised size of US$ 3165 million by 2031, growing at a CAGR of 11.3% during the forecast period.

cfDNA Testing Market

cfDNA testing is an advanced molecular diagnostic technology that uses the analysis of extracellular DNA fragments in the blood for disease screening, diagnosis, and monitoring. These DNA fragments primarily originate from genetic material released during cell apoptosis or necrosis, and their length is typically between 160 and 180 base pairs. In healthy individuals, cfDNA remains at a relatively stable low level, but its content and characteristics change significantly under specific physiological or pathological conditions such as pregnancy, organ transplantation, and tumors. Core applications of this technology include non-invasive prenatal testing, which screens for fetal chromosomal aneuploidy by analyzing fetal-derived cfDNA in maternal blood; tumor liquid biopsy, which detects ctDNA carrying specific gene mutations released by tumor cells for early cancer screening, companion diagnostics, efficacy evaluation, and recurrence monitoring; and post-transplant rejection monitoring, which assesses the transplanted organ's condition by analyzing the proportion of donor-derived cfDNA. Compared to traditional tissue biopsies, cfDNA testing offers advantages such as being minimally invasive, highly reproducible, and capable of reflecting tumor heterogeneity, making it an important tool in precision medicine. With the continuous development of sequencing technology and bioinformatics analysis, its application in clinical practice is constantly expanding.

North American market for cfDNA Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for cfDNA Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for cfDNA Testing in Prenatal Testing is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of cfDNA Testing include Illumina, Oncogenomics, Revvity, CareDx, Natera, BillionToOne, Inc., Yourgene Health, ARUP Laboratories, Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for cfDNA Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding cfDNA Testing.

The cfDNA Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global cfDNA Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, by Test Type and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the cfDNA Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of cfDNA Testing Market Report

Report Metric	Details
Report Name	cfDNA Testing Market
Accounted market size in year	US$ 1500 million
Forecasted market size in 2031	US$ 3165 million
CAGR	11.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Targeted Sequencing Whole Genome Sequencing
Segment by Test Type	Services Reagent Kits Others Segment Target Audiences LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions DTC (Direct-to-Consumer) Services for Consumers
Segment by Application	Prenatal Testing Oncology Organ Transplant Monitoring Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Illumina, Oncogenomics, Revvity, CareDx, Natera, BillionToOne, Inc., Yourgene Health, ARUP Laboratories, Roche
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Test Type etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of cfDNA Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is cfDNA Testing Market growing?

Ans: The cfDNA Testing Market witnessing a CAGR of 11.3% during the forecast period 2025-2031.

What is the cfDNA Testing Market size in 2031?

Ans: The cfDNA Testing Market size in 2031 will be US$ 3165 million.

Who are the main players in the cfDNA Testing Market report?

Ans: The main players in the cfDNA Testing Market are Illumina, Oncogenomics, Revvity, CareDx, Natera, BillionToOne, Inc., Yourgene Health, ARUP Laboratories, Roche

What are the Application segmentation covered in the cfDNA Testing Market report?

Ans: The Applications covered in the cfDNA Testing Market report are Prenatal Testing, Oncology, Organ Transplant Monitoring, Others

What are the Type segmentation covered in the cfDNA Testing Market report?

Ans: The Types covered in the cfDNA Testing Market report are Services, Reagent Kits, Others, Segment Target Audiences, LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions, DTC (Direct-to-Consumer) Services for Consumers

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global cfDNA Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Targeted Sequencing

1.2.3 Whole Genome Sequencing

1.3 Market by Test Type

1.3.1 Global cfDNA Testing Market Size Growth Rate by Test Type: 2020 VS 2024 VS 2031

1.3.2 Services

1.3.3 Reagent Kits

1.3.4 Others

1.4 Market Target Audiences

1.4.1 Global cfDNA Testing Market Size Growth Rate Target Audiences: 2020 VS 2024 VS 2031

1.4.2 LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions

1.4.3 DTC (Direct-to-Consumer) Services for Consumers

1.5 Market by Application

1.5.1 Global cfDNA Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Prenatal Testing

1.5.3 Oncology

1.5.4 Organ Transplant Monitoring

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global cfDNA Testing Market Perspective (2020-2031)

2.2 Global cfDNA Testing Growth Trends by Region

2.2.1 Global cfDNA Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 cfDNA Testing Historic Market Size by Region (2020-2025)

2.2.3 cfDNA Testing Forecasted Market Size by Region (2026-2031)

2.3 cfDNA Testing Market Dynamics

2.3.1 cfDNA Testing Industry Trends

2.3.2 cfDNA Testing Market Drivers

2.3.3 cfDNA Testing Market Challenges

2.3.4 cfDNA Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top cfDNA Testing Players by Revenue

3.1.1 Global Top cfDNA Testing Players by Revenue (2020-2025)

3.1.2 Global cfDNA Testing Revenue Market Share by Players (2020-2025)

3.2 Global Top cfDNA Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by cfDNA Testing Revenue

3.4 Global cfDNA Testing Market Concentration Ratio

3.4.1 Global cfDNA Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by cfDNA Testing Revenue in 2024

3.5 Global Key Players of cfDNA Testing Head office and Area Served

3.6 Global Key Players of cfDNA Testing, Product and Application

3.7 Global Key Players of cfDNA Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 cfDNA Testing Breakdown Data by Type

4.1 Global cfDNA Testing Historic Market Size by Type (2020-2025)

4.2 Global cfDNA Testing Forecasted Market Size by Type (2026-2031)

5 cfDNA Testing Breakdown Data by Application

5.1 Global cfDNA Testing Historic Market Size by Application (2020-2025)

5.2 Global cfDNA Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America cfDNA Testing Market Size (2020-2031)

6.2 North America cfDNA Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America cfDNA Testing Market Size by Country (2020-2025)

6.4 North America cfDNA Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe cfDNA Testing Market Size (2020-2031)

7.2 Europe cfDNA Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe cfDNA Testing Market Size by Country (2020-2025)

7.4 Europe cfDNA Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific cfDNA Testing Market Size (2020-2031)

8.2 Asia-Pacific cfDNA Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific cfDNA Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific cfDNA Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America cfDNA Testing Market Size (2020-2031)

9.2 Latin America cfDNA Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America cfDNA Testing Market Size by Country (2020-2025)

9.4 Latin America cfDNA Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa cfDNA Testing Market Size (2020-2031)

10.2 Middle East & Africa cfDNA Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa cfDNA Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa cfDNA Testing Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Details

11.1.2 Illumina Business Overview

11.1.3 Illumina cfDNA Testing Introduction

11.1.4 Illumina Revenue in cfDNA Testing Business (2020-2025)

11.1.5 Illumina Recent Development

11.2 Oncogenomics

11.2.1 Oncogenomics Company Details

11.2.2 Oncogenomics Business Overview

11.2.3 Oncogenomics cfDNA Testing Introduction

11.2.4 Oncogenomics Revenue in cfDNA Testing Business (2020-2025)

11.2.5 Oncogenomics Recent Development

11.3 Revvity

11.3.1 Revvity Company Details

11.3.2 Revvity Business Overview

11.3.3 Revvity cfDNA Testing Introduction

11.3.4 Revvity Revenue in cfDNA Testing Business (2020-2025)

11.3.5 Revvity Recent Development

11.4 CareDx

11.4.1 CareDx Company Details

11.4.2 CareDx Business Overview

11.4.3 CareDx cfDNA Testing Introduction

11.4.4 CareDx Revenue in cfDNA Testing Business (2020-2025)

11.4.5 CareDx Recent Development

11.5 Natera

11.5.1 Natera Company Details

11.5.2 Natera Business Overview

11.5.3 Natera cfDNA Testing Introduction

11.5.4 Natera Revenue in cfDNA Testing Business (2020-2025)

11.5.5 Natera Recent Development

11.6 BillionToOne, Inc.

11.6.1 BillionToOne, Inc. Company Details

11.6.2 BillionToOne, Inc. Business Overview

11.6.3 BillionToOne, Inc. cfDNA Testing Introduction

11.6.4 BillionToOne, Inc. Revenue in cfDNA Testing Business (2020-2025)

11.6.5 BillionToOne, Inc. Recent Development

11.7 Yourgene Health

11.7.1 Yourgene Health Company Details

11.7.2 Yourgene Health Business Overview

11.7.3 Yourgene Health cfDNA Testing Introduction

11.7.4 Yourgene Health Revenue in cfDNA Testing Business (2020-2025)

11.7.5 Yourgene Health Recent Development

11.8 ARUP Laboratories

11.8.1 ARUP Laboratories Company Details

11.8.2 ARUP Laboratories Business Overview

11.8.3 ARUP Laboratories cfDNA Testing Introduction

11.8.4 ARUP Laboratories Revenue in cfDNA Testing Business (2020-2025)

11.8.5 ARUP Laboratories Recent Development

11.9 Roche

11.9.1 Roche Company Details

11.9.2 Roche Business Overview

11.9.3 Roche cfDNA Testing Introduction

11.9.4 Roche Revenue in cfDNA Testing Business (2020-2025)

11.9.5 Roche Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global cfDNA Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Targeted Sequencing

Table 3. Key Players of Whole Genome Sequencing

Table 4. Global cfDNA Testing Market Size Growth Rate by Test Type (US$ Million): 2020 VS 2024 VS 2031

Table 5. Key Players of Services

Table 6. Key Players of Reagent Kits

Table 7. Key Players of Others

Table 8. Global cfDNA Testing Market Size Growth Rate Target Audiences (US$ Million): 2020 VS 2024 VS 2031

Table 9. Key Players of LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions

Table 10. Key Players of DTC (Direct-to-Consumer) Services for Consumers

Table 11. Global cfDNA Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 12. Global cfDNA Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 13. Global cfDNA Testing Market Size by Region (2020-2025) & (US$ Million)

Table 14. Global cfDNA Testing Market Share by Region (2020-2025)

Table 15. Global cfDNA Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 16. Global cfDNA Testing Market Share by Region (2026-2031)

Table 17. cfDNA Testing Market Trends

Table 18. cfDNA Testing Market Drivers

Table 19. cfDNA Testing Market Challenges

Table 20. cfDNA Testing Market Restraints

Table 21. Global cfDNA Testing Revenue by Players (2020-2025) & (US$ Million)

Table 22. Global cfDNA Testing Market Share by Players (2020-2025)

Table 23. Global Top cfDNA Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in cfDNA Testing as of 2024)

Table 24. Ranking of Global Top cfDNA Testing Companies by Revenue (US$ Million) in 2024

Table 25. Global 5 Largest Players Market Share by cfDNA Testing Revenue (CR5 and HHI) & (2020-2025)

Table 26. Global Key Players of cfDNA Testing, Headquarters and Area Served

Table 27. Global Key Players of cfDNA Testing, Product and Application

Table 28. Global Key Players of cfDNA Testing, Date of Enter into This Industry

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global cfDNA Testing Market Size by Type (2020-2025) & (US$ Million)

Table 31. Global cfDNA Testing Revenue Market Share by Type (2020-2025)

Table 32. Global cfDNA Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 33. Global cfDNA Testing Revenue Market Share by Type (2026-2031)

Table 34. Global cfDNA Testing Market Size by Application (2020-2025) & (US$ Million)

Table 35. Global cfDNA Testing Revenue Market Share by Application (2020-2025)

Table 36. Global cfDNA Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 37. Global cfDNA Testing Revenue Market Share by Application (2026-2031)

Table 38. North America cfDNA Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. North America cfDNA Testing Market Size by Country (2020-2025) & (US$ Million)

Table 40. North America cfDNA Testing Market Size by Country (2026-2031) & (US$ Million)

Table 41. Europe cfDNA Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Europe cfDNA Testing Market Size by Country (2020-2025) & (US$ Million)

Table 43. Europe cfDNA Testing Market Size by Country (2026-2031) & (US$ Million)

Table 44. Asia-Pacific cfDNA Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 45. Asia-Pacific cfDNA Testing Market Size by Region (2020-2025) & (US$ Million)

Table 46. Asia-Pacific cfDNA Testing Market Size by Region (2026-2031) & (US$ Million)

Table 47. Latin America cfDNA Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Latin America cfDNA Testing Market Size by Country (2020-2025) & (US$ Million)

Table 49. Latin America cfDNA Testing Market Size by Country (2026-2031) & (US$ Million)

Table 50. Middle East & Africa cfDNA Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 51. Middle East & Africa cfDNA Testing Market Size by Country (2020-2025) & (US$ Million)

Table 52. Middle East & Africa cfDNA Testing Market Size by Country (2026-2031) & (US$ Million)

Table 53. Illumina Company Details

Table 54. Illumina Business Overview

Table 55. Illumina cfDNA Testing Product

Table 56. Illumina Revenue in cfDNA Testing Business (2020-2025) & (US$ Million)

Table 57. Illumina Recent Development

Table 58. Oncogenomics Company Details

Table 59. Oncogenomics Business Overview

Table 60. Oncogenomics cfDNA Testing Product

Table 61. Oncogenomics Revenue in cfDNA Testing Business (2020-2025) & (US$ Million)

Table 62. Oncogenomics Recent Development

Table 63. Revvity Company Details

Table 64. Revvity Business Overview

Table 65. Revvity cfDNA Testing Product

Table 66. Revvity Revenue in cfDNA Testing Business (2020-2025) & (US$ Million)

Table 67. Revvity Recent Development

Table 68. CareDx Company Details

Table 69. CareDx Business Overview

Table 70. CareDx cfDNA Testing Product

Table 71. CareDx Revenue in cfDNA Testing Business (2020-2025) & (US$ Million)

Table 72. CareDx Recent Development

Table 73. Natera Company Details

Table 74. Natera Business Overview

Table 75. Natera cfDNA Testing Product

Table 76. Natera Revenue in cfDNA Testing Business (2020-2025) & (US$ Million)

Table 77. Natera Recent Development

Table 78. BillionToOne, Inc. Company Details

Table 79. BillionToOne, Inc. Business Overview

Table 80. BillionToOne, Inc. cfDNA Testing Product

Table 81. BillionToOne, Inc. Revenue in cfDNA Testing Business (2020-2025) & (US$ Million)

Table 82. BillionToOne, Inc. Recent Development

Table 83. Yourgene Health Company Details

Table 84. Yourgene Health Business Overview

Table 85. Yourgene Health cfDNA Testing Product

Table 86. Yourgene Health Revenue in cfDNA Testing Business (2020-2025) & (US$ Million)

Table 87. Yourgene Health Recent Development

Table 88. ARUP Laboratories Company Details

Table 89. ARUP Laboratories Business Overview

Table 90. ARUP Laboratories cfDNA Testing Product

Table 91. ARUP Laboratories Revenue in cfDNA Testing Business (2020-2025) & (US$ Million)

Table 92. ARUP Laboratories Recent Development

Table 93. Roche Company Details

Table 94. Roche Business Overview

Table 95. Roche cfDNA Testing Product

Table 96. Roche Revenue in cfDNA Testing Business (2020-2025) & (US$ Million)

Table 97. Roche Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. cfDNA Testing Picture

Figure 2. Global cfDNA Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global cfDNA Testing Market Share by Type: 2024 VS 2031

Figure 4. Targeted Sequencing Features

Figure 5. Whole Genome Sequencing Features

Figure 6. Global cfDNA Testing Market Size Comparison by Test Type (2020-2031) & (US$ Million)

Figure 7. Services Features

Figure 8. Reagent Kits Features

Figure 9. Others Features

Figure 10. Global cfDNA Testing Market Size Comparison Target Audiences (2020-2031) & (US$ Million)

Figure 11. LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions Features

Figure 12. DTC (Direct-to-Consumer) Services for Consumers Features

Figure 13. Global cfDNA Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 14. Global cfDNA Testing Market Share by Application: 2024 VS 2031

Figure 15. Prenatal Testing Case Studies

Figure 16. Oncology Case Studies

Figure 17. Organ Transplant Monitoring Case Studies

Figure 18. Others Case Studies

Figure 19. cfDNA Testing Report Years Considered

Figure 20. Global cfDNA Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 21. Global cfDNA Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 22. Global cfDNA Testing Market Share by Region: 2024 VS 2031

Figure 23. Global cfDNA Testing Market Share by Players in 2024

Figure 24. Global cfDNA Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 25. The Top 10 and 5 Players Market Share by cfDNA Testing Revenue in 2024

Figure 26. North America cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. North America cfDNA Testing Market Share by Country (2020-2031)

Figure 28. United States cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Canada cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe cfDNA Testing Market Share by Country (2020-2031)

Figure 32. Germany cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. France cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. U.K. cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Italy cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Russia cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Ireland cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific cfDNA Testing Market Share by Region (2020-2031)

Figure 40. China cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Japan cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Southeast Asia cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. India cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Australia & New Zealand cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America cfDNA Testing Market Share by Country (2020-2031)

Figure 48. Mexico cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Brazil cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa cfDNA Testing Market Share by Country (2020-2031)

Figure 52. Israel cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. UAE cfDNA Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Illumina Revenue Growth Rate in cfDNA Testing Business (2020-2025)

Figure 56. Oncogenomics Revenue Growth Rate in cfDNA Testing Business (2020-2025)

Figure 57. Revvity Revenue Growth Rate in cfDNA Testing Business (2020-2025)

Figure 58. CareDx Revenue Growth Rate in cfDNA Testing Business (2020-2025)

Figure 59. Natera Revenue Growth Rate in cfDNA Testing Business (2020-2025)

Figure 60. BillionToOne, Inc. Revenue Growth Rate in cfDNA Testing Business (2020-2025)

Figure 61. Yourgene Health Revenue Growth Rate in cfDNA Testing Business (2020-2025)

Figure 62. ARUP Laboratories Revenue Growth Rate in cfDNA Testing Business (2020-2025)

Figure 63. Roche Revenue Growth Rate in cfDNA Testing Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions